Theragenics Corporation (TGX)

2.02 -0.02  -0.98%  May 21, 8:00PM
Add to Watchlists Create an Alert

Theragenics Corporation R&D Expense Quarterly:

0.263M for Dec. 31, 2012
View Full Chart

Theragenics Corporation R&D Expense Quarterly Chart

    Theragenics Corporation Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 0.263M
    Sept. 30, 2012 0.281M
    June 30, 2012 0.312M
    March 31, 2012 0.277M
    Dec. 31, 2011 0.274M
    Sept. 30, 2011 0.38M
    June 30, 2011 0.46M
    March 31, 2011 0.535M
    Dec. 31, 2010 0.559M
    Sept. 30, 2010 0.529M
    June 30, 2010 0.414M
    March 31, 2010 0.44M
    Dec. 31, 2009 0.448M
    Sept. 30, 2009 0.521M
    June 30, 2009 0.588M
    March 31, 2009 0.603M
    Dec. 31, 2008 0.633M
    Sept. 30, 2008 0.373M
    June 30, 2008 0.161M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    TGX R&D Expense Quarterly Benchmarks

    Companies
    IsoRay 0.1492M
    C.R. Bard 59.30M
    Abiomed 6.822M

    TGX R&D Expense Quarterly Rankings

    Overall 81st percentile
    1478 of 8002
    Sector 32nd percentile
    464 of 684 in Healthcare
    Industry 19th percentile
    75 of 93 in Medical Devices

    TGX R&D Expense Quarterly Range, Past 5 Years

    Minimum 0.1610M Jun 2008
    Maximum 0.6330M Dec 2008
    Average 0.4237M